Dynamic solution Co (290660) Fair Value & Analysis
Healthcare · KR · Market cap 47.4B KRW
Fair value as of: Jul 7, 2026
From 1 valuation models · updated today
Fair value updated Jul 7, 2026 — revised from 4,754 KRW to 304.96 KRW (−93.6%) since Jun 24, 2026. Share price +96.4% over the past month.
Price vs Fair Value (12 months)
12‑month range 664.00 KRW – 1,983 KRW · fair‑value band 201.28 KRW – 381.20 KRW · the 1,689 KRW price screens above the 304.96 KRW fair value. As of Jul 7, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Dynamic solution Co (290660) currently trades at 1,689 KRW, while our model-based Fair Value estimate is 304.96 KRW — implying the stock looks roughly 81.9% overvalued today. We read business quality at 41/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 15.5B KRW. Revenue declined 16.0% year over year. It earns a return on equity of -31.9%. Net debt stands at 3.2B KRW. Fundamentals as of Jul 7, 2026
Our scenario range runs from 201.28 KRW (bear case) to 381.20 KRW (bull case); at 1,689 KRW, the current price sits above that range. The share trades about 12% below its 52-week high and 164% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -20% fair-value upside — at -82%, 290660 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 7, 2026. TTM = trailing twelve months.
About the company
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to promote improved functional reach and muscle control; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect Smart Table for dementia prevention and rehabilitation program; Neomano, a wearable robotic glove; Neofect Comcog, a cognitive rehabilitation program that helps patients with stroke, dementia, traumatic brain injury, brain tumor, and cerebral palsy; and …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dynamic solution Co reported revenue of 16.1B KRW in FY2025 versus 23.2B KRW in FY2021, a compound −8.8%/yr. Reported net income was −12.3B KRW in FY2025.
Is 290660 fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABTT34 | R$38.22 | R$30.39 | -20% |
| Stryker Corporation S1YK34 | R$77.83 | R$8.47 | -89% |
| Medtronic plc MDTC34 | R$211.05 | R$29.52 | -86% |
| Boston Scientific Corporation B1SX34 | R$248.75 | R$221.81 | -11% |
| Edwards Lifesciences Corporation EW | $85.98 | $41.02 | -52% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
| GE HealthCare Technologies Inc GEHC | $63.76 | $44.97 | -29% |
| DexCom, Inc DXCM | $69.07 | $65.56 | -5% |
| Koninklijke Philips N.V 1PHIA | €24.31 | €9.97 | -59% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Dynamic solution Co (290660) undervalued?
What is the fair value of 290660?
What is the quality score of 290660?
What is the revenue of Dynamic solution Co (290660)?
What is the net profit margin of 290660?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.